INGN Q3 2017 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$69M+26.8% YoY

Gross Profit

$33M48.1% margin

Operating Income

$8M12.1% margin

Net Income

$7M10.6% margin

EPS (Diluted)

$0.33

QoQ Revenue Growth

+7.7%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$270M

Total Liabilities

$49M

Stockholders' Equity

$221M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$54M	+26.8%
Gross Profit	$33M	$25M	+32.0%
Operating Income	$8M	$5M	+54.4%
Net Income	$7M	$3M	+112.4%

Geographic Segments

UNITED STATES

$52M75%

Non Us

$17M25%